Umbelliferone Induces Changes In The Structure And Pharmacological Activities Of Bn Iv, A Phospholipase A2 Isoform Isolated From Bothrops Neuwiedi

In this paper was demonstrated that umbelliferone induces changes in structure and pharmacological activities of Bn IV, a lysine 49 secretory phospholipase A2 (sPLA2) from Bothrops neuwiedi. Incubation of Bn IV with umbelliferone virtually abolished platelet aggregation, edema, and myotoxicity induced by native Bn IV. The amino acid sequence of Bn IV showed high sequence similarities with other Lys49 sPLA2s from B. jararacussu (BthTx-I), B. pirajai (PrTx-I), and B. neuwiedi pauloensis (Bn SP6 and Bn SP7). This sPLA2 also has a highly conserved C-terminal amino acid sequence, which has been shown as important for the pharmacological activities of Lys49 sPLA2. Sequencing of Bn IV previously treated with umbelliferone revealed modification of S(1) and S(20). Fluorescent spectral analysis and circular dichroism (CD) studies showed that umbelliferone modified the secondary structure of this protein. Moreover, the pharmacological activity of Bn IV is driven by synergism of the C-terminal region with the α-helix motifs, which are involved in substrate binding of the Asp49 and Lys49 residues of sPLA2 and have a direct effect on the Ca2+-independent membrane damage of some secretory snake venom PLA2. For Bn IV, these interactions are potentially important for triggering the pharmacological activity of this sPLA2. © 2011 Elsevier Ltd.576851860Chan, A.C., Pritchard, E.T., Gerrard, J.M., Man, R.Y., Choy, P.C., Biphasic modulation of platelet phospholipase A2 activity and platelet aggregation by mepacrine (quinacrine) (1982) Biochim. Biophys. Acta., 713 (1), pp. 170-172Chioato, L., Ward, R.J., Mapping structural determinants of biological activities in snake venom phospholipases A2 by sequence analysis and site directed mutagenesis (2003) Toxicon, 42 (8), pp. 869-883Chioato, L., Aragão, E.A., Lopes Ferreira, T., Medeiros, A.I., Faccioli, L.H., Ward, R.J., Mapping of the structural determinants of artificial and biological membrane damaging activities of a Lys49 phospholipase A2 by scanning alanine mutagenesis (2007) Biochim. Biophys. Acta., 1768 (5), pp. 1247-1257Cintra, A.C., Marangoni, S., Oliveira, B., Giglio, J.R., Bothropstoxin-I: amino acid sequence and function (1993) J. Protein Chem., 12 (1), pp. 57-64Di Carlo, G., Mascolo, N., Izzo, A.A., Capasso, F., Flavonoids: old and new aspects of a class of natural therapeutic drugs (1999) Life Sci., 65, pp. 337-353dos Santos, M.L., Fagundes, F.H., Teixeira, B.R., Toyama, M.H., Aparicio, R., Purification and preliminary crystallographic analysis of a new Lys49-PLA2 from B. Jararacussu (2008) Int. J. Mol. Sci., 9 (5), pp. 736-750Diz Filho, E.B., Marangoni, S., Toyama, D.O., Fagundes, F.H., Oliveira, S.C., Fonseca, F.V., Calgarotto, A.K., Toyama, M.H., Enzymatic and structural characterization of new PLA2 isoform isolated from white venom of Crotalus durissus ruruima (2009) Toxicon, 53 (1), pp. 104-114Fawzy, A.A., Vishwanath, B.S., Franson, R.C., Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action (1988) Agents Actions, 25, pp. 394-400Fonseca, F.V., Baldissera, L., Camargo, E.A., Antunes, E., Diz-Filho, E.B., Corrêa, A.G., Beriam, L.O., Toyama, M.H., Effect of the synthetic coumarin, ethyl 2-oxo-2H-chromene-3-carboxylate, on activity of Crotalus durissus ruruima sPLA2 as well as on edema and platelet aggregation induced by this factor (2010) Toxicon, 55 (8), pp. 1527-1530. , JFuly, A.L., Soares, A.M., Marcussi, S., Giglio, J.R., Guimar̃aes, J.A., Signal transduction pathways involved in the platelet aggregation induced by a D-49 phospholipase A2 isolated from Bothrops jararacussu snake venom (2004) Biochimie, 86, pp. 731-739Gil, B., Sanz, M.J., Terencio, M.C., Gunasegaran, R., Payá, M., Alcaraz, M.J., Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity (1997) Biochem Pharmacol., 53 (5), pp. 733-740Ghani, U., Ng, K.K., Atta-ur-Rahman Choudhary, M.I., Ullah, N., James, M.N., Crystal structure of gamma-chymotrypsin in complex with 7-hydroxycoumarin (2001) J Mol Biol., 314 (3), pp. 519-525Gutiérrez, J.M., Ownby, C.L., Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity (2003) Toxicon, 42 (8), pp. 915-931Hefner, Y., Borsch-Haubold, A.G., Murakami, M., Wilde, J.I., Pasquet, S., Schieltz, D., Ghomashchi, F., Gelb, M.H., Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases (2000) J. Biol. Chem., 275 (48), pp. 37542-37551Henrikson, R.L., Meredith, S.C., Amino acid analysis by reverse phase high performance liquid chromatography: pre-column derivatization with phenylisothiocyanate (1984) Anal. Biochem., 136, pp. 65-71Holland, J.A., Pritchard, K.A., Pappolla, M.A., Wolin, M.S., Rogers, N.J., Stemerman, M.B., Bradykinin induces superoxide anion release from human endothelial cells (1990) J. Cell Physiol., 143 (1), pp. 21-25Iglesias, C.V., Aparicio, R., Rodrigues-Simioni, L., Camargo, E.A., Antunes, E., Marangoni, S., Toyama, D.O., Toyama, M.H., Effects of morin on snake venom phospholipase A(2) (PLA(2) (2005) Toxicon, 46, pp. 751-758Kostova, I., Monolov, I., Karaivonova, M., Synthesis, physicochemical characterization, and cytotoxic screening of new zirconium complexes with coumarin derivatives (2001) Arch. Pharm. (Weinheim), 334, pp. 157-162Kramer, R.M., Roberts, E.F., Manetta, J.V., Hyslop, P.A., Jakubowski, J.A., Thrombin-induced phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in human platelets (1993) J. Biol. Chem., 268, pp. 26796-26804Kramer, R.M., Roberts, E.F., Um, S.L., Börsch-Haubold, A.G., Watson, S.P., Fisher, M.J., Jakubowski, J.A., P38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2 (1996) J. Biol. Chem., 271 (44), pp. 27723-27729Kroll, M.H., Schafer, A.I., Biochemical mechanisms of platelet activation (1989) Blood, 74 (4), pp. 1181-1195Leung, L., Nachman, R., Molecular mechanisms of platelet aggregation (1986) Annu. Rev. Med., 37, pp. 179-186Lindahl, M., Tagesson, C., Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2 (1997) Inflammation, 21, pp. 347-356Lomonte, B., Angulo, Y., Calderón, L., An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action (2003) Toxicon, 42 (8), pp. 885-901Magro, A.J., Soares, A.M., Giglio, J.R., Fontes, M.R., Crystal structures of BnSP-7 and BnSP-6, two Lys49-phospholipases A(2): quaternary structure and inhibition mechanism insights (2003) Biochem. Biophys. Res. Comm., 311 (3), pp. 713-720Marshall, L.A., Chang, J.Y., Calhoun, W., Yu, J., Carlson, R.P., Preliminary studies on phospholipase A2-induced mouse paw edema as a model to evaluate antiinflammatory agents (1989) J. Cell Biochem., 40 (2), pp. 147-155Massini, P., Lüscher, E.F., On the significance of the influx of calcium ions into stimulated human blood platelets (1976) Biochim Biophys Acta., 436 (3), pp. 652-663Murray, R.D., Coumarins (1989) Nat. Prod. Rep., 6, pp. 591-624Nirmal, N., Praba, G.O., Velmurugan, D., Modeling studies on phospholipase A2-inhibitor complexes (2008) Indian J. Biochem. Biophys., 45 (4), pp. 256-262Oliveira, C.F., Lopes, D.S., Mendes, M.M., Homsi-Brandeburgo, M.I., Hamaguchi, A., de Alcântara, T.M., Clissa, P.B., Rodrigues, V.M., Insights of local tissue damage and regeneration induced by BnSP-7, a myotoxin isolated from Bothrops (neuwiedi) pauloensis snake venom (2009) Toxicon, 53 (5), pp. 560-569Polgár, J., Kramer, R.M., Um, S.L., Jakubowski, J.A., Clemetson, K.J., Human group II 14 kDa phospholipase A2 activates human platelets (1997) Biochem. J, 327 (PART 1), pp. 259-265Puri, R.N., Phospholipase A2: its role in ADP- and thrombin-induced platelet activation mechanisms (1998) Int. J. Biochem. Cell Biol., 30, pp. 1107-1122Qin, S., Pande, A.H., Nemec, K.N., Tatulian, S.A., The N-terminal alpha-helix of pancreatic phospholipase A2 determines productive-mode orientation of the enzyme at the membrane surface (2004) J. Mol. Biol., 344 (1), pp. 71-89Qin, S., Pande, A.H., Nemec, K.N., He, X., Tatulian, S.A., Evidence for the regulatory role of the N-terminal helix of secretory phospholipase A(2) from studies on native and chimeric proteins (2005) J. Biol. Chem., 280 (44), pp. 36773-36783Rotelli, A.E., Guardia, T., Juárez, A.O., de la Rocha, N.E., Pelzer, L.E., Comparative study of flavonoids in experimental models of inflammation (2003) Pharmacol. Res., 48, pp. 601-606Schagger, H., von Jagow, G., Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa (1987) Anal. Biochem., 1, pp. 368-379Soares, A.M., Andrião-Escarso, S.H., Bortoleto, R.K., Rodrigues-Simioni, L., Arni, R.K., Ward, R.J., Gutiérrez, J.M., Giglio, J.R., Dissociation of enzymatic and pharmacological properties of piratoxins-I and -III, two myotoxic phospholipases A2 from Bothrops pirajai snake venom (2001) Arch. Biochem. Biophys., 387 (2), pp. 188-196Toyama, M.H., Soares, A.M., Vieira, C.A., Novello, J.C., Oliveira, B., Giglio, J.R., Marangoni, S., Amino acid sequence of piratoxin-I, a myotoxin from Bothrops pirajai snake venom, and its biological activity after alkylation with p-bromophenacyl bromide (1998) J. Protein Chem., 17 (7), pp. 713-718Toyama, M.H., Carneiro, E.M., Marangoni, S., Barbosa, R.L., Corso, G., Boschero, A.C., Biochemical characterization of two crotamine isoforms isolated by a single step RP-HPLC from Crotalus durissus terrificus (South American rattlesnake) venom and their action on insulin secretion by pancreatic islets (2000) Biochim. Biophys. Acta, 1474, pp. 56-60Toyama, M.H., Soares, A.M., Wen-Hwa, L., Polikarpov, I., Giglio, J.R., Marangoni, S., Amino acid sequence of piratoxin-II, a myotoxic lys49 phospholipase A(2) homologue from Bothrops pirajai venom (2000) Biochimie, 82 (3), pp. 245-250Toyama, M.H., de Oliveira, D.G., Beriam, L.O., Novello, J.C., Rodrigues-Simioni, L., Marangoni, S., Structural, enzymatic and biological properties of new PLA(2) isoform from Crotalus durissus terrificus venom (2003) Toxicon, 41, pp. 1033-1038Toyama, M.H., Toyama, D.O., Joazeiro, P.P., Carneiro, E.M., Beriam, L.O.S., Marangoni, S., Boschero, A.C., Biological and structural characterization of a new PLA(2) from the Crotalus durissus collilineatus venom (2005) Protein J., 24, pp. 103-112Toyama, D.O., Marangoni, S., Diz-Filho, E.B., Oliveira, S.C., Toyama, M.H., Effect of umbelliferone (7-hydroxycoumarin, 7-HOC) on the enzymatic, edematogenic and necrotic activities of secretory phospholipase A2 (sPLA2) isolated from Crotalus durissus collilineatus venom (2009) Toxicon, 53 (4), pp. 417-426Vincent, J.E., Zijlstra, F.J., Biphasic effects of phospholipase A2 on platelet aggregation. Effect of prostaglandin synthesis inhibitors and essential fatty acid deficiency (1976) Prostaglandins, 12 (6), pp. 971-979Vishwanath, B.S., Fawzy, A.A., Franson, R.C., Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid (1988) Inflammation, 12, pp. 549-56